The Impact of Pelvic Lymph-Node Dissection and of its Extent on Biochemical Relapse After Radical Prostatectomy in Patients with Pathological no or Nx at Intermediate and High Risk of Lymph-Node Invasion
Schiavina, R.; Franceschelli, A.; Bertaccini, A.; Manferrari, F.; Garofalo, M.; Dababne, U.; Pernetti, R.; Guidi, M.; Vagnoni, V.; Molducci, S.; Martorana, G.
European Urology Supplements 9(2): 264-265
2010
DOI: 10.1016/s1569-9056(10)60812-3
Accession: 070204768
PDF emailed within 0-6 h: $19.90
Related References
Schiavina, R.; Bertaccini, A.; Franceschelli, A.; Manferrari, F.; Vagnoni, V.; Borghesi, M.; Morselli-Labate, A.M.; Martorana, G. 2010: The impact of the extent of lymph-node dissection on biochemical relapse after radical prostatectomy in node-negative patients Anticancer Research 30(6): 2297-2302Moris, L.; Van den Broeck, T.; Tosco, L.; Van Baelen, A.; Gontero, P.; Karnes, R.Jeffrey.; Everaerts, W.; Albersen, M.; Bastian, P.J.; Chlosta, P.; Claessens, F.; Chun, F.K.; Graefen, M.; Gratzke, C.; Kneitz, B.; Marchioro, G.; Salas, R.Sanchez.; Tombal, B.; Van Der Poel, H.; Walz, J.Christoph.; De Meerleer, G.; Bossi, A.; Haustermans, K.; Montorsi, F.; Van Poppel, H.; Spahn, M.; Briganti, A.; Joniau, S. 2016: Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection Frontiers in Surgery 3: 65
Winter, A.; Uphoff, J.; Henke, R-Peter.; Wawroschek, F. 2012: Complete PSA Remission without Adjuvant Therapy after Secondary Lymph Node Surgery in Selected Patients with Biochemical Relapse after Radical Prostatectomy and Pelvic Lymph Node Dissection Advances in Urology 2012: 609612
Narita, T.; Koie, T.; Ookubo, T.; Mitsuzuka, K.; Narita, S.; Yamamoto, H.; Inoue, T.; Hatakeyama, S.; Kawamura, S.; Tochigi, T.; Habuchi, T.; Arai, Y.; Ohyama, C. 2017: The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis Medical Oncology 34(1): 1
Silberstein, J.L.; Vickers, A.J.; Power, N.E.; Parra, R.O.; Coleman, J.A.; Pinochet, R.; Touijer, K.A.; Scardino, P.T.; Eastham, J.A.; Laudone, V.P. 2012: Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures Journal of Endourology 26(6): 748-753
Preisser, F.; Bandini, M.; Marchioni, M.; Nazzani, S.; Tian, Z.; Pompe, R.S.; Fossati, N.; Briganti, A.; Saad, F.; Shariat, S.F.; Heinzer, H.; Huland, H.; Graefen, M.; Tilki, D.; Karakiewicz, P.I. 2018: Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion Prostate 78(6): 469-475
Leyh-Bannurah, S-Ramzi.; Budäus, L.; Zaffuto, E.; Pompe, R.S.; Bandini, M.; Briganti, A.; Montorsi, F.; Schiffmann, J.; Shariat, S.F.; Fisch, M.; Chun, F.; Huland, H.; Graefen, M.; Karakiewicz, P.I. 2018: Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification Urologic Oncology 36(2): 81.E17-81.E24
Peeters, C.; Ponette, D.; van Poppel, H. 2017: Salvage Pelvic Lymph Node Dissection after Radical Prostatectomy for Biochemical and Lymph Node Recurrence Urologia Internationalis 98(3): 367-369
Briganti, A.; Karakiewicz, P.I.; Chun, F.K-H.; Gallina, A.; Salonia, A.; Zanni, G.; Valiquette, L.; Graefen, M.; Huland, H.; Rigatti, P.; Montorsi, F. 2007: Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection European Urology 51(6): 1573-1581
Bivalacqua, T.J.; Pierorazio, P.M.; Gorin, M.A.; Allaf, M.E.; Carter, H.Ballentine.; Walsh, P.C. 2013: Anatomic extent of pelvic lymph node dissection: impact on long-term cancer-specific outcomes in men with positive lymph nodes at time of radical prostatectomy Urology 82(3): 653-658
Daimon, T.; Miyajima, A.; Maeda, T.; Hattori, S.; Yasumizu, Y.; Hasegawa, M.; Kosaka, T.; Kikuchi, E.; Nakagawa, K.; Oya, M. 2012: Does pelvic lymph node dissection improve the biochemical relapse-free survival in low-risk prostate cancer patients treated by laparoscopic radical prostatectomy? Journal of Endourology 26(9): 1199-1202
Weight, C.J.; Reuther, A.M.; Gunn, P.W.; Zippe, C.R.; Dhar, N.B.; Klein, E.A. 2008: Limited pelvic lymph node dissection does not improve biochemical relapse-free survival at 10 years after radical prostatectomy in patients with low-risk prostate cancer Urology 71(1): 141-145
Heck, M.; Retz, M.; Bandur, M.; Souchay, M.; Vitzthum, E.; Weirich, G.; Schuster, T.; Autenrieth, M.; Kübler, H.; Maurer, T.; Thalgott, M.; Herkommer, K.; Gschwend, J.; Nawroth, R. 2017: Prospective comparison of molecular and histopathologic detection of lymph node metastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: Prediction of biochemical recurrence European Urology Suppls 16(3): E1517-E1518
Briganti, A.; Capitanio, U.; Abdollah, F.; Gallina, A.; Suardi, N.; Bianchi, M.; Tutolo, M.; Salonia, A.; Freschi, M.; Rigatti, P.; Montorsi, F. 2012: Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool Prostate 72(5): 499-506
Schiavina, R.; Brunocilla, E.; Borghesi, M.; Vagnoni, V.; Romagnoli, D.; Della Mora, L.; Cevenini, M.; Del Prete, C.; Mengoni, F.; Diazzi, D.; Martorana, G. 2014: Prognostic value of lymph node density in prostate cancer node-positive patients treated with radical prostatectomy and pelvic lymph node dissection European Urology Suppls 13(1): e167-e167a
Briganti, A.; Karakiewicz, P.I.; Chun, F.K-H.; Suardi, N.; Gallina, A.; Abdollah, F.; Freschi, M.; Doglioni, C.; Rigatti, P.; Montorsi, F. 2009: Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection International Journal of Urology: Official Journal of the Japanese Urological Association 16(8): 676-681
Briganti, A.; Capitanio, U.; Chun, F.K-H.; Gallina, A.; Suardi, N.; Salonia, A.; Da Pozzo, L.F.; Colombo, R.; Di Girolamo, V.; Bertini, R.; Guazzoni, G.; Karakiewicz, P.I.; Montorsi, F.; Rigatti, P. 2008: Impact of surgical volume on the rate of lymph node metastases in patients undergoing radical prostatectomy and extended pelvic lymph node dissection for clinically localized prostate cancer European Urology 54(4): 794-802
Porcaro, A.B.; Tafuri, A.; Sebben, M.; Processali, T.; Pirozzi, M.; Amigoni, N.; Rizzetto, R.; Shakir, A.; Cerruto, M.Angela.; Brunelli, M.; Siracusano, S.; Artibani, W. 2020: High body mass index predicts multiple prostate cancer lymph node metastases after radical prostatectomy and extended pelvic lymph node dissection Asian Journal of Andrology 22(3): 323-329
Passoni, N.M.; Bianchi, M.; Abdollah, F.; Gallina, A.; Suardi, N.; Matloob, R.; Tutolo, M.; Fossati, N.; Zanni, G.E.; Colombo, R.; Cozzarini, C.; Salonia, A.; Rigatti, P.; Montorsi, F.; Briganti, A. 2013: Head-To-Head Comparison of Lymph Node Density and Number of Positive Lymph Nodes in Stratifying the Outcome of Patients with Lymph Node Positive Prostate Cancer Submitted to Radical Prostatectomy and Extended Pelvic Lymph Node Dissection The Journal of Urology 189(4): e318-e319
Abdollah, F.; Cozzarini, C.; Sun, M.; Suardi, N.; Gallina, A.; Passoni, Nò.Maria.; Bianchi, M.; Tutolo, M.; Fossati, N.; Nini, A.; Dell'oglio, P.; Salonia, A.; Karakiewicz, P.; Montorsi, F.; Briganti, A. 2013: Assessing the most accurate formula to predict the risk of lymph node metastases from prostate cancer in contemporary patients treated with radical prostatectomy and extended pelvic lymph node dissection RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 109(2): 211-216